Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia

Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia

Background: Patients with high-risk acute leukemia have a high risk of relapse after allogeneic stem cell transplantation (allo-SCT). In an effort to reduce the relapse rate, various therapeutic methods have been implemented into clinical practice. Among them, prophylactic donor lymphocyte infusion...

Full description

Bibliographic Details
Main Authors:	Panagiotis Tsirigotis, Konstantinos Gkirkas, Vassiliki Kitsiou, Spiros Chondropoulos, Theofilos Athanassiades, Thomas Thomopoulos, Alexandra Tsirogianni, Maria Stamouli, Aggeliki Karagiannidi, Nikolaos Siafakas, Vassiliki Pappa, Arnon Nagler
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Cancers
Subjects:	prophylactic donor lymphocyte infusion allogeneic stem cell transplantation high-risk acute leukemia prevention of relapse graft versus host disease
Online Access:	https://www.mdpi.com/2072-6694/13/11/2699

Similar Items

Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas
by: Maria Stamouli, et al.
Published: (2021-06-01)

Alterations of Peripheral Blood T Cell Subsets following Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation
by: Ann-Kristin Schmaelter, et al.
Published: (2021-11-01)

Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene Editing
by: Yoshiki Furukawa, et al.
Published: (2022-01-01)

Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation
by: Dionysios Vythoulkas, et al.
Published: (2023-01-01)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
by: Michael Stadler, et al.
Published: (2022-08-01)

Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor
by: Dionysios Vythoulkas, et al.
Published: (2023-04-01)

Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion
by: Eva A. S. Koster, et al.
Published: (2023-08-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
by: Christine Greil, et al.
Published: (2021-12-01)

Donor Lymphocyte Infusion to Enhance the Graft-versus-Myeloma Effect
by: Nico Gagelmann, et al.
Published: (2021-04-01)

Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation
by: Eva A. S. Koster, et al.
Published: (2024-03-01)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
by: Kyle B. Lupo, et al.
Published: (2019-06-01)

Comparison of Post-transplant Cyclophosphamide Containing Immunosuppressive Regimen with Standard Immunosuppressive Regimen in Allogeneic Stem Cell Transplantation from Matched Sibling Donor
by: Osman KARA, et al.
Published: (2021-12-01)

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
by: Argiris Symeonidis, et al.
Published: (2022-08-01)

Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience
by: Justin Jiang, et al.
Published: (2022-11-01)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
by: Zachariah DeFilipp, et al.
Published: (2019-08-01)

MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
by: Katrin Teich, et al.
Published: (2023-08-01)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
by: Nidhi Sharma, et al.
Published: (2021-02-01)

Lower expression of NOTCH components in peripheral blood mononuclear cells of allogeneic hematopoietic cell transplant patients
by: Marcos Paulo Colella, et al.
Published: (2023-07-01)

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants
by: Maria Iacobescu, et al.
Published: (2024-02-01)

Characterization of dynamical changes in vital signs during allogeneic human umbilical cord-derived mesenchymal stem cells infusion
by: Yue Wang, et al.
Published: (2023-12-01)

Cytomegalovirus Infection and Treatment in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from a Single Institution in an Endemic Area
by: Hsin - Chen Lin, et al.
Published: (2017-05-01)

Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
by: Elisa Roldan, et al.
Published: (2019-09-01)

The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
by: Robert Puckrin, et al.
Published: (2023-01-01)

Advances in Intestinal Barrier Preservation and Restoration in the Allogeneic Hematopoietic Cell Transplantation Setting
by: Martyna Tyszka, et al.
Published: (2021-06-01)

Increased Intestinal Permeability and Stool Zonulin, Calprotectin and Beta-Defensin-2 Concentrations in Allogenic Hematopoietic Cell Transplantation Recipients
by: Martyna Tyszka, et al.
Published: (2022-12-01)

RESULTS OF ALLOGENIC BONE MARROW TRANSPLANTATION IN CML IN IRAN
by: A. khodabeh., et al.
Published: (1998-06-01)

Study protocol: Phase I/II trial of induced HLA-G+ regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor
by: Memnon Lysandrou, et al.
Published: (2023-05-01)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-09-01)

Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
by: Jinichi Mori, et al.
Published: (2023-08-01)

Tumor vaccine strategies after allogeneic T-cell depleted bone marrow transplantation
by: Ferrara James L.M.
Published: (2002-01-01)

Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse
by: Ivan Odak, et al.
Published: (2022-10-01)

Allogeneic Mesenchymal Stromal Cells as a Global Pediatric Prospective Approach in the Treatment of Respiratory Failure Associated with Surfactant Protein C Dysfunction
by: Gloria Pelizzo, et al.
Published: (2023-01-01)

Long-Term Analysis of Resilience of the Oral Microbiome in Allogeneic Stem Cell Transplant Recipients
by: Alexa M. G. A. Laheij, et al.
Published: (2022-03-01)

The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation
by: Sook-Kyoung Heo, et al.
Published: (2022-09-01)

HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation
by: Sebastian Klobuch, et al.
Published: (2020-05-01)

Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
by: Adrianna Spałek, et al.
Published: (2022-11-01)

Intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation: case report
by: Jing Yuan, et al.
Published: (2023-03-01)